Mary Reumuth

CIK: 0001710969

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (83.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KALA

KALA BIO, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

KALA
KALA BIO, Inc.
Oct 23, 2025
Sale(S)
Direct
967 shares at avg. $0.82$792.94
KALA
KALA BIO, Inc.
Oct 22, 2025
Sale(S)
Direct
32.2K shares at avg. $0.83$27K
KALA
KALA BIO, Inc.
Jun 24, 2025
Sale(S)
Direct
3.6K shares at avg. $4.01$15K
KALA
KALA BIO, Inc.
Jun 3, 2025
Sale(S)
Direct
2.9K shares at avg. $3.74$11K
KALA
KALA BIO, Inc.
Jan 6, 2025
Award(A)
Direct
10.1K shares-
KALA
KALA BIO, Inc.
Jan 6, 2025
Sale(S)
Direct
1.7K shares at avg. $7.63$13K

		Type	Shares	Price		Ownership
Oct 23, 2025	KALA KALA BIO, Inc.	Sale(S)	967	$0.82	$793	Direct
Oct 22, 2025	KALA KALA BIO, Inc.	Sale(S)	32,230	$0.83	$26,751	Direct
Jun 24, 2025	KALA KALA BIO, Inc.	Sale(S)	3,631	$4.01	$14,560	Direct
Jun 3, 2025	KALA KALA BIO, Inc.	Sale(S)	2,850	$3.74	$10,659	Direct
Jan 6, 2025	KALA KALA BIO, Inc.	Award(A)	10,100	-	$0	Direct
Jan 6, 2025	KALA KALA BIO, Inc.	Sale(S)	1,706	$7.63	$13,017	Direct

1-6 of 6 transactions

About Reumuth Mary

Reumuth Mary (SEC CIK 0001710969) files insider reports with the SEC as CHIEF FINANCIAL OFFICER of KALA BIO, Inc. (KALA).

Signal8 holds 4 ownership filings by Reumuth Mary, all Form 4s, filed between Jan 7, 2025 and Oct 24, 2025. Those filings report 6 transactions, from Jan 6, 2025 to Oct 23, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Reumuth Mary's filings is in ARLINGTON, MA.

Recent filings by Reumuth Mary

Oct 23, 2025: Open-market sale of KALA shares (Form 4, code S).
Oct 22, 2025: Open-market sale of KALA shares (Form 4, code S).
Jun 24, 2025: Open-market sale of KALA shares (Form 4, code S).
Jun 3, 2025: Open-market sale of KALA shares (Form 4, code S).
Jan 6, 2025: Grant or award of KALA shares (Form 4, code A).

Other insiders filing for KALA BIO, Inc. (KALA)

Purdy Brendan P., Director
Posen Hillel D., Director
Minkowitz Avraham, Chief Executive Officer
Colman Yonatan C., Director
Berger Chaim D., Director
Lazar David E., Chief Executive Officer

How to read Form 4 transaction codes